$65 million: Aclaris buying rights to rosacea drug from Allergan
October 16, 2018 at 11:52 AM EDT
Aclaris has entered into a deal for the rights to a rosacea treatment its senior managers helped develop while at the helm of a different Chester County biopharmaceutical company.
